Site Search      
Home About Us Technology Products Investors Clinical Trials Careers Contact Us
Contact Us
Directions to GlobeImmune
Press Release Sign Up
GlobeImmune’s Hepatitis C Product Candidate Improves End of Treatment Response in All IL-28 B Genotypes, with the Greatest Effect in the Hardest-to-Treat Patients

GlobeImmune GI-5005 HCV Product Candidate Improves Sustained Virologic Response by 10 Percent, Demonstrating Potential to be First Therapeutic Vaccine for HCV

GlobeImmune Announces Presentations of GI-5005 Phase 2b Data at EASL 2010 Meeting

 


Contact Us

Please feel free to contact us with any questions you may have.

Contact Us


Corporate Headquarters
1450 Infinite Drive
Louisville, Colorado 80027
 
Phone:    303.625.2700
Fax:    303.625.2710
Desired Contact :
Your Name : Required
Company Name :
Telephone No. : Required
E-Mail Address : Required
Contact Message
 
Letters in Image Above: Required
 


Copyright © GlobeImmune Inc. All Rights Reserved.
Developed by Mango Media Corporation